CNS Pharmaceuticals Inc (CNSP)
1.59
-0.07
(-4.22%)
USD |
NASDAQ |
Jun 28, 16:00
1.58
-0.01
(-0.63%)
After-Hours: 20:00
CNS Pharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.0022M |
September 30, 2023 | -0.0017M |
June 30, 2023 | 0.00 |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | -0.0015M |
June 30, 2022 | -0.0029M |
March 31, 2022 | |
December 31, 2021 | -0.0021M |
September 30, 2021 | 0.00 |
Date | Value |
---|---|
June 30, 2021 | 0.00 |
March 31, 2021 | -0.0037M |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | -0.0115M |
March 31, 2020 | -0.0064M |
December 31, 2019 | -0.0117M |
September 30, 2019 | 0.00 |
June 30, 2019 | -0.0084M |
March 31, 2019 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.0117M
Minimum
Dec 2019
--
Maximum
Dec 2022
-0.0027M
Average
-0.0016M
Median
Cash from Investing (Quarterly) Benchmarks
SIGA Technologies Inc | 0.00 |
Moderna Inc | 118.00M |
Allurion Technologies Inc | -0.104M |
Calidi Biotherapeutics Inc | -0.005M |
NovaBay Pharmaceuticals Inc | 1.068M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -3.192M |
Cash from Financing (Quarterly) | 3.459M |
Free Cash Flow | -12.51M |
Free Cash Flow Per Share (Quarterly) | -18.32 |
Free Cash Flow Yield | -6.85K% |